Intracranial Aneurysm-Standard Treatment Guidelines

Published On 2017-01-30 09:12 GMT   |   Update On 2017-01-30 09:12 GMT

Intracranial aneurysms are focal outpouching from intracranial arteries with weak walls as compared to normal arteries and therefore have propensity to present with intracranial bleed, usually subarachnoid hemorrhage (SAH). Clinically, these cases present with sudden severe headache (‘thunderclap headache’) in case of bleed (1-6). Occasionally, these lesions may grow to significant size without bleeding and manifest clinically because of compression of adjoining brain parenchyma or cranial nerves (2-4).


Introduction


The word aneurysm comes from the Latin word ‘aneurysma’, which means dilatation. Aneurysm is an abnormal focal dilatation in the wall of a blood vessel, usually an artery, due to a defect, disease, or injury (5,6). Aneurysms can be true or false. A false aneurysm is a cavity lined by blood clot. The 3 major types of intracranial aneurysms are saccular, fusiform, and dissecting (1,6).


Ministry of Health and Family Welfare, Government of India has issued the Standard Treatment Guidelines for Intracranial Aneurysm.
Following are the major recommendations :

Case definition


Any patient presenting with or suspected to have non traumatic subarachnoid hemorrhage (SAH) or uncommonly, focal neurological deficit with demonstration of aneurysm on Imaging should be suspected of harboring an aneurysm (3-6).


Incidence of the condition in our country


It is underdiagnosed, undertreated, and much more common than previously thought. Incidence of the condition in our country is not exactly known due to lack of organized data. International literature suggests incidence between 1-6% in general population.


Differential Diagnosis


Clinically, other causes of ‘thunderclap headache’ merit consideration (1-6). These include cerebral venous thrombosis, cervical dissection, migraine, pituitary bleed, reversible cerebral vasoconstriction (Call Flemming syndrome). Radiologically, other causes of subarachnoid hemorrhage need consideration which are trauma, brain arteriovenous malformations (AVMs), bleeding disorders and other rare causes.


Prevention and Counselling


At this time, a routine screening test to discover brain may not be required without clinical symptoms. However, certain modifiable risk factors as follows should be adequately controlled to prevent bleed:


i. Cigarette smoking – increases the risk of an aneurysm rupture. Smokers are three times more likely to have an SAH than non-smokers.


ii. Alcohol & drugs use - It is unclear if alcohol use increases the risk of developing an aneurysm, but moderate to heavy drinking is considered a risk factor for the rupture of an aneurysm if present. Similarly, drug use, particularly cocaine, may increase the risk of rupture.


iii. High Blood Pressure – several studies found that having high blood pressure increases the risk for developing an aneurysm and for rupture of existing aneurysms (7).


Optimal Diagnostic Criteria, Investigations, Treatment & Referral Criteria -
Diagnostic Criteria

Aneurysm should be considered in the following clinical setting (1,5,6) :

i) Sudden severe headache (‘thunderclap headache’) in the absence of obvious head injury.

ii) Presence of SAH on imaging (CT/MRI)

iii) Demonstration of aneurysm on imaging during evaluation for any neurologic problem.

Investigations

i) CT Scan

CT scan should be sought on any patient with non-traumatic SAH. Large Aneurysms or their wall calcification may also be at times seen on NCCT.

ii) CT Angiogram (CTA)

Conventional angiography like images of the cerebral vasculature can be obtained using rapid contrast infusion and thin-section dynamic CT scanning (CTA). Various 3-dimensional display techniques, including shaded surface display, volume rendering, and maximum intensity projection, are used to complement the conventional transaxial images. It has very high diagnostic accuracy with sensitivity and specificity of >95% (8-10).

iii) MR Angiogram (MRA)

MRA should be usually performed only if there is some contraindication to CTA or CT cannot be easily performed. The sensitivity and specificity is lower as compared to CTA (11).

iv) Digital Subtraction Angiogram (DSA)

It remains the gold standard for diagnosis, particularly in delineating small aneurysms. DSA is usually always required in case any endovascular or surgical treatment is planned (6,8).

Treatment

Two major strategies for treatment are:

(1) To closely follow up in case of incidentally detected asymptomatic aneurysms by clinical and radiological re assessment periodically.

(2) In symptomatic group, treatment options include endovascular coiling of the sac or surgical clipping of the aneurysm neck.

Referral Criteria

*Situation 1: At Secondary Hospital/ Non-Metro situation: Optimal Standards of Treatment in Situations where technology and resources are limited:


Clinical diagnosis




  • Subarachnoid hemorrhage: The most common presentation of intracranial aneurysm is subarachnoid hemorrhage (SAH) in non traumatic background. On presentation, patients typically report experiencing the worst headache of their lives (thunderclap headache). The association of meningeal signs should increase suspicion of SAH.

  • Mass effect: The so-called giant aneurysms (diameter >2.5 cm) are more often symptomatic because of their mass effect. Some intracranial aneurysms produce cranial neuropathies. A common example is the third nerve palsy that is secondary to posterior communicating artery aneurysm or III/IV/VI nerve palsy seen in giant cavernous ICA aneurysms. Rarely, even visual loss caused by an ophthalmic artery aneurysm that compresses the optic nerve has been reported.

  • Other symptoms: Other, less common, symptoms include seizures, headaches, and transient ischemic attacks or cerebral infarction secondary to emboli (usually associated with large or giant partially thrombosed aneurysms). Severe vasospasm associated with SAH is often the leading cause of death.


Investigations


i) CT-to confirm SAH or to look for diagnostic possibility of aneurysm as a cause for focal neurologic deficit.


ii) CTA/MRA-if available, to confirm the diagnosis before referring to higher center.


Treatment


Based on the available literature, the management of aneurysm differs in ruptured and unruptured patients (1, 5,6, 12,13).


Ruptured aneurysms should be treated urgently (within 72 h of hemorrhage) to prevent rebleeding and to permit aggressive Management of vasospasm.


Unruptured aneurysms are generally treated electively and may even be followed up if small (<7mm) and incidentally detected.


Initial management for Ruptured Aneurysms :




  • Administer calcium channel blockers (nimodipine for 21 d) to all patients; this has been shown to improve outcome (6,14).

  • Anticonvulsant use is controversial, but is generally given (levetiracetam or phenytoin), particularly for patients undergoing craniotomy or those with focal cerebral hematomas in addition to the SAH.


Ventricular drainage: Blood in the subarachnoid space obliterates the arachnoidal villi / ventricular foramina, causing acute hydrocephalus. In life threatening state, a ventriculostomy catheter should be emergently placed (6).


Definite Management: Endovascular coiling or Surgical Clipping - To be done at higher center with expertise and infrastructure.


Referral criteria
A diagnosed or suspected case of aneurysm which warrants urgent or early intervention due to presentation (SAH or neurological deficits) should be referred to tertiary care center with facilities for endovascular treatment or neurosurgery as early as possible.

*Situation 2: At Super Specialty Facility in Metro location where higher-end technology is available


Case Definition (tertiary care)


Clinical diagnosis:




  • Subarachnoid hemorrhage:The most common presentation of intracranial aneurysm is subarachnoid hemorrhage (SAH) in non traumatic background. On presentation, patients typically report experiencing the worst headache of their lives (thunderclap headache). The association of meningeal signs should increase suspicion of SAH.

  • Mass effect: The so-called giant aneurysms (diameter >2.5 cm) are more often symptomatic because of their mass effect. Some intracranial aneurysms produce cranial neuropathies. A common example is the third nerve palsy that is secondary to posterior communicating artery aneurysm or III/IV/VI nerve palsy seen in giant cavernous ICA aneurysms. Rarely, even visual loss caused by an ophthalmic artery aneurysm that compresses the optic nerve has been reported.

  • Other symptoms: Other, less common, symptoms include seizures, headaches, and transient ischemic attacks or cerebral infarction secondary to emboli (usually associated with large or giant partially thrombosed aneurysms).


Severe vasospasm associated with SAH is often the leading cause of death.

Investigations:

i) CT Scan - to confirm SAH or to look for diagnostic possibility of aneurysm as a cause for focal neurologic deficit Large Aneurysms or their wall calcification may also be at times seen on NCCT.

ii) CT Angiogram (CTA) – Angiography like images of the cerebral vasculature can be obtained using rapid contrast infusion and thin-section dynamic CT scanning (CTA). Various 3- dimensional display techniques, including shaded surface display, volume rendering, and maximal intensity projection, are used to complement the conventional transaxial images (8-10).

iii) MR Angiogram (MRA)- MRA should be usually performed only if there is some contraindication to CTA or CT cannot be easily performed (6,11).

iv) Digital Subtraction Angiogram (DSA)- It remains the gold standard for diagnosis, particularly small aneurysms. DSA is usually always required in case any endovascular or surgical treatment is planned (1,5,6).

Treatment

Initial treatment and evaluation:
As outlined above. If not already started, supportive treatment should be started immediately.

Definite Management: Endovascular coiling or Surgical Clipping
Obliteration of an aneurysm can be done by either putting metallic (usually titanium) clips at the aneurysm neck (‘clipping’) or by packing the aneurysm sac from inside by using platinum coils (‘coiling’) through endovascular (transarterial) route. While clipping is a major surgical procedure, coiling is a minimally invasive technique and therefore appears more attractive. However, the choice of procedure depends on various other factors and needs to be decided carefully. Recent evidence suggests that coiling is highly effective and in certain conditions (eg posterior circulation aneurysms) much more favored option (13,17-20).

Referral criteria

A diagnosed or suspected case of aneurysm which warrants urgent or early intervention due to presentation (SAH or neurodeficts) should be refered to tertiary care center with facilities for endovascular treatment or neurosurgery.





































































DesignationClinical RoleTimeline
Physician (Internist)Clinical EvaluationScreening on presentation to OP
General Surgeon (GS)Clinical Evaluation & supervising vascular evaluationSpecialist Consultant who becomes the primary care Physician once diagnosis is established
Performs Vascular SurgeryWhen indicated or when IR procedures fail.
BiochemistBiochemical evaluationAfter evaluation by and on the request of GS
Diagnostic RadiologistEvaluate NCCT, CTA or MRAAfter evaluation by and on the request of GS
NeurosurgeonNeurologic evaluationAfter consultation by and on the request of GS
Management of SAH and surgical clippingIf necessary, following GS consult and on the request of GS
InterventionalIR Procedures – Endovascular coiling,Referring Specialist for IR
Radiologistparent artery occlusion if safe, endovascular bypass device (flow diverters)procedures on the request of GS/ NS
Nursing StaffAssist in managing the patientn-patient or Day Care in Vascular Surgery facility, Dialysis facility and Interventional Radiology facility
TechnicianAssist in Imaging the patientIn CT,MR and Interventional Radiology facility after Radiology & IR consultation

RESOURCES REQUIRED FOR ONE PATIENT / PROCEDURE (PATIENT WEIGHT 60 KGS)

(Units to be specified for human resources, investigations, drugs & consumables and equipment. Quantity to also be specified)
























SITUATIONHUMAN RESOURCESINVESTIGATIONSDRUGS & CONSUMABLESEQUIPMENT
1.Doctors –

(Internist – 1,

General Surgeon – 1,

Diagnostic Radiologist

-1,

Technician(s) – 3,

Nursing - 2
Hemoglobin,

Random Blood

Sugar, PT, APTT

or INR, Platelet

Count, Se.

Creatinine,

HBsAg, HIV
1. Drugs:

Nimodipine, Heparin
MDCT or MRI with

facility for Vascular

Imaging
2.Doctors –

(Internist – 1,

Vascular Surgeon with

– 1, Diagnostic

Radiologist -1,

Interventional

Radiologist – 1,

Anaesthetist -1)

Technician(s) – 3 to 4

Nurses – 3 to 4 for all

the units
Hemoglobin,

Random Blood

Sugar, PT, APTT

or INR, Platelet

Count, Se.

Creatinine,

HBsAg, HIV
1. Drugs:

Nimodipine, Heparin,

Non Ionic

radiographic contrast

media

2. Consumables:

Arterial access

device, Diagnostic

Catheter, Guiding

catheter, balloon or

self expanding Stent,

GDC platinum coils
Vascular Doppler(1)

Operation Theatre

(1)

Color Doppler

Ultrasound (1)

MDCT or MRI with

Vascular Imaging (1)

Digital Subtraction

Angiography

System (1)

Sterile Suite

Multichannel

invasive monitor (1) Resuscitation equipment (1) Crash Trolley (1)

Guidelines by The Ministry of Health and Family Welfare :

Dr. Chander Mohan
Dr. B.L. Kapur Hospital
New Delhi

 
Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News

NICE Guidelines on Latent TB